Zhejiang Taimei Medical Technology Co., Ltd. (TAIMEI TECH) disclosed a new share repurchase completed on 10 June 2026. Key details are as follows:
• Transaction size and pricing TAIMEI TECH repurchased 100,000 H-shares on the Hong Kong Stock Exchange at prices between HKD 4.37 and HKD 4.49, for a volume-weighted average of HKD 4.4494. Total consideration amounted to HKD 0.44 million.
• Impact on share capital Issued shares outstanding (excluding treasury shares) fell 0.05 % to 200.17 million, while treasury shares rose to 421,000. Total issued shares remain unchanged at 200.59 million.
• Repurchase mandate utilisation The buy-back forms part of the mandate approved on 13 June 2025, which authorises repurchases of up to 20.06 million shares. Cumulative repurchases under this mandate now stand at 421,000 shares, equivalent to 0.21 % of the share base on the mandate date.
• Post-repurchase restrictions Under Hong Kong listing rules, the company is subject to a moratorium on new share issues or transfers of treasury shares until 10 July 2026.
The company confirms all transactions complied with the Main Board rules of the Hong Kong Stock Exchange.